Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity

by Jørgen Smeby, Kushtrim Kryeziu, Kaja C.G. Berg, Ina A. Eilertsen, Peter W. Eide, Bjarne Johannessen, Marianne G. Guren, Arild Nesbakken, Jarle Bruun, Ragnhild A. Lothe, Anita Sveen
Published 2020-09-01

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer

by Jørgen Smeby, Anita Sveen, Christian H Bergsland, Ina A Eilertsen, Stine A Danielsen, Peter W Eide, Merete Hektoen, Marianne G Guren, Arild Nesbakken, Jarle Bruun, Ragnhild A Lothe
Published 2019-06-01